Edition:
United States

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

35.79USD
11:34am EST
Change (% chg)

$-1.19 (-3.22%)
Prev Close
$36.98
Open
$36.60
Day's High
$36.60
Day's Low
$35.60
Volume
400,144
Avg. Vol
1,716,830
52-wk High
$39.43
52-wk Low
$24.79

Chart for

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $40,477.75
Shares Outstanding(Mil.): 1,372.13
Dividend: --
Yield (%): --

Financials

  BSX.N Industry Sector
P/E (TTM): 51.69 195.05 34.39
EPS (TTM): 0.57 -- --
ROI: 5.48 9.63 14.96
ROE: 11.71 15.55 16.52

Edwards owes Boston Scientific $35 mln in heart valve patent case - jury

A federal jury in Delaware has ordered medical device maker Edwards Lifesciences Corp to pay $35 million after finding a heart valve replacement system it makes infringes a patent held by rival Boston Scientific Corp.

Dec 12 2018

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 21 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn (US$4.22bn)bridge loan from Barclays Bank.

Nov 21 2018

Deals of the day-Mergers and acquisitions

Nov 20 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

Nov 20 2018

Boston Scientific backs BTG offer with £3.3bn bridge loan

LONDON, Nov 20 (LPC) - US medical device maker Boston Scientific is backing its recommended cash offer for UK-based BTG plc with a £3.3bn bridge loan from Barclays Bank.

Nov 20 2018

Boston Scientific builds medical technology with $4.2 billion BTG deal

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.

Nov 20 2018

UPDATE 2-Boston Scientific builds medical tech with $4.2 billion BTG deal

* U.S. group's biggest deal since 2006 Guidant acquisition (Adds latest shares, analyst comment, further details)

Nov 20 2018

Boston Scientific offers to buy UK's BTG for about $4.24 billion

Nov 20 U.S. medical device maker Boston Scientific Corp said it offered to buy British pharmaceutical firm BTG Plc for about 3.3 billion pounds ($4.24 billion) in cash.

Nov 20 2018

Surgical product sales drive Boston Scientific's profit beat

Medical device company Boston Scientific Corp posted a slightly better-than-expected quarterly profit on Wednesday, helped by higher sales in its MedSurg business, which makes surgical products for various urological and pelvic disorders.

Oct 24 2018

UPDATE 2-Surgical product sales drive Boston Scientific's profit beat

* Co tightens EPS forecast on foreign exchange headwinds (Adds details from conference call, analyst comment; Updates shares)

Oct 24 2018

Boston Scientific posts 53 percent jump in third-quarter profit

Oct 24 Medical device maker Boston Scientific Corp posted a 52.7 percent jump in quarterly profit on Wednesday, helped by higher sales in its cardiovascular business, which makes stents and heart valves.

Oct 24 2018

Earnings vs. Estimates